Osaic Holdings’s Lisata Therapeutics LSTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1K Buy
200
+100
+100% +$413 ﹤0.01% 7263
2025
Q4
$186 Buy
+100
New +$222 ﹤0.01% 7589
2025
Q1
Sell
-1
Closed -$2 7606
2024
Q4
$2 Hold
1
﹤0.01% 7378
2024
Q3
$3 Hold
1
﹤0.01% 7374
2024
Q2
$3 Hold
1
﹤0.01% 7373
2024
Q1
$3 Hold
1
﹤0.01% 7169
2023
Q4
$2 Sell
1
-1
-50% -$2 ﹤0.01% 7270
2023
Q3
$4 Buy
2
+1
+100% +$3 ﹤0.01% 7358
2023
Q2
$3 Sell
1
-2
-67% -$7 ﹤0.01% 7434
2023
Q1
$9 Hold
3
﹤0.01% 7456
2022
Q4
$0 Sell
3
-348
-99% -$1.28K ﹤0.01% 7334
2022
Q3
$2K Sell
351
-3
-0.8% -$22 ﹤0.01% 6789
2022
Q2
$3K Hold
354
﹤0.01% 6732
2022
Q1
$4K Buy
354
+2
+0.6% +$23 ﹤0.01% 6611
2021
Q4
$4K Hold
352
﹤0.01% 6754
2021
Q3
$6K Sell
352
-1
-0.3% -$20 ﹤0.01% 6449
2021
Q2
$8K Hold
353
﹤0.01% 6194
2021
Q1
$10K Buy
353
+1
+0.3% +$30 ﹤0.01% 5869
2020
Q4
$7K Sell
352
-233
-40% -$5.53K ﹤0.01% 5654
2020
Q3
$16K Hold
585
﹤0.01% 5028
2020
Q2
$16K Hold
585
﹤0.01% 4922
2020
Q1
$16K Buy
+585
New +$22.7K ﹤0.01% 4761

Other funds holding LSTA

Osaic Holdings's LSTA Position: Q1 2026 in Review

Osaic Holdings increased its Lisata Therapeutics (LSTA) stake by 100% in Q1 2026, buying an estimated $413 and bringing the position to 200 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #7263.

Osaic Holdings first reported a position in LSTA in Q1 2020 and has held it in 22 quarters since. The position peaked at $16K in Q3 2020. 34 funds tracked by Wall St. Rank hold LSTA as of Q1 2026.

  • Osaic Holdings held 200 shares of Lisata Therapeutics worth $1K as of Q1 2026.
  • Osaic Holdings bought 100 Lisata Therapeutics shares in Q1 2026, an estimated $413.
  • Lisata Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7263 holding.
  • Osaic Holdings first reported a position in Lisata Therapeutics in Q1 2020 and has held it in 22 quarters since.
  • Osaic Holdings's Lisata Therapeutics position peaked at $16K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.